Click on image to open expanded view
Item No.
28599
Reconcile Flavored Chewable Tablets for Dogs Rx
Availability:
-
In Stock
AutoShip & Save 20%
Strength:
Count:
Product Description
Reconcile (fluoxetine hydrochloride) is a daily chewable flavored tablet for the treatment of separation anxiety in dogs in conjunction with a behavior modification plan. Reconcile is approved by the FDA to help manage separation anxiety and improves your dog's receptivity to behavior modification. Available in 30 chewable tablet bottles in the following strengths / dog weights : 8 mg (8.8-17.6 lbs), 16 mg (17.7-35.2 lbs), 32 mg (35.3-70.4 lbs), 64 mg (70.5-140.8 lbs).
What is Reconcile Flavored Chewable Tablets for Dogs?
Reconcile is a daily flavored chewable tablet for the treatment of separation anxiety in dogs. This medication improves your pet’s receptivity and aids in behavior modification during dog training.
Who is Reconcile Flavored Chewable Tablets for Dogs for?
Dogs & Puppies (8 weeks or older and weighing 8.8 lbs or more)
Why use Reconcile Flavored Chewable Tablets for Dogs?
- For the treatment of separation anxiety in dogs
- Fluoxetine works without sedation
- Helps modify behavior associated with separation anxiety
- Reduces the frequency and severity of anxiety symptoms
How does Reconcile Flavored Chewable Tablets for Dogs work?
The active ingredient in RECONCILE chewable tablets is fluoxetine hydrochloride, a selective serotonin reuptake inhibitor (SSRI). This affects the chemicals in your pets body that cause anxiety, depression, panic and obsessive compulsive behaviors.
Manufacturer:
PRN Pharmacal, Inc.
Active Ingredients(s):
Fluoxetine Hydrochloride
How is Reconcile Flavored Chewable Tablets for Dogs sold?
30 flavored chewable tablet bottles in the following strengths depending on your dogs weight : 8 mg (8.8-17.6 lbs), 16 mg (17.7-35.2 lbs), 32 mg (35.3-70.4 lbs), 64 mg (70.5-140.8 lbs)
What are the side effects of Reconcile Flavored Chewable Tablets for Dogs?
*Seizures may occur in dogs treated with RECONCILE chewable tablets, even in dogs without a history of epilepsy or seizures. Other possible side effects include : Lethargy/Depression, Decreased Appetite, Vomiting, Tremors, Diarrhea or Restlessness.
What special precautions are there?
Keep away from children and animals. NOT for human use. Reconcile chewable tablets are contraindicated for use in dogs with epilepsy or a history of seizures. Reconcile chewable tablets should not be given concomitantly with drugs that lower the seizure threshold (e.g., phenothiazines such as acepromazine or chlorpromazine). Reconcile chewable tablets should not be given in combination with a monoamine oxidase inhibitor (MAOI) [e.g., selegiline hydrochloride (L-deprenyl) or amitraz], or within a minimum of 14 days of discontinuing therapy with an MAOI. Reconcile chewable tablets are contraindicated in dogs with a known hypersensitivity to fluoxetine HCl or other SSRIs. Because fluoxetine and its major metabolite, norfluoxetine, have long half-lives, a 6-week washout interval should be observed following discontinuation of therapy with Reconcile chewable tablets prior to the administration of any drug that may adversely interact with fluoxetine or norfluoxetine. Reconcile chewable tablets are not recommended for the treatment of aggression.
What to do if overdose?
Contact your nearest emergency animal hospital
How can I store Reconcile Flavored Chewable Tablets for Dogs?
Store at 20-25°C (68-77°F). Excursions permitted between 15-30°C (59-86°F). Do not remove desiccant canister from the bottle. Completely close bottle between uses.
Helpful Tips:
Before prescribing RECONCILE chewable tablets, a comprehensive physical examination should be conducted to rule out causes of inappropriate behavior unrelated to separation anxiety.
Overview
RECONCILE chewable tablets are indicated for the treatment of canine separation anxiety in conjunction with a behavior modification plan.
The recommended dose of RECONCILE chewable tablets is 1-2 mg/kg (0.5-0.9 mg/lb) administered once daily, in conjunction with a behavior modification plan. A typical behavior modification plan consists of the pet owner implementing standard training techniques based on principles such as rewarding appropriate behavior; coming and going in a manner that does not elicit inappropriate responses from the dog; and teaching the dog to be content while alone.
Reconcile Administration for dogs and puppies (8 weeks or older)
Weight Dosage
8.8 – 17.6 lbs 8 mg 1 Tablet
17.7 – 35.2 lbs 16mg 1 Tablet
35.3 – 70.4 lbs 32mg 1 Tablet
70.5 – 140.8 lbs 64mg 1 Tablet
Main Ingredients
Fluoxetine Hydrochloride